Nifty

:

24870.10

Sensex

:

81306.85

-213.65 (-0.85%)
-693.86 (-0.85%)

Login

Nifty
Sensex

:
:

24870.10
81306.85

-213.65 (-0.85%)
-693.86 (-0.85%)

Supriya Lifescience Ltd.

Pharmaceuticals & Drugs

Rating :

72/99

BSE: 543434 | NSE: SUPRIYA

Watchlist

NSE BSE

689.55

22-Aug-2025

Open
High
Low
Previous Close

688
693.7
683.1
695.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

82294
56763898.8
842
511.4

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,546.87
31.14
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,467.72
0.15%
5.38

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.26
12.85
2.47

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.19
12.30
-3.87

PAT CAGR (%)

10 Years
5 Years
3 Years

30.67
10.17
-7.77

P:E (Median)

8 Years
5 Years
3 Years

-
-
24.46

P:BV (Average)

8 Years
5 Years
3 Years

-
-
4.11

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
15.47

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 14.8 23.35 27.6 30.7
P/E Ratio 46.59 29.53 24.98 22.46
Revenue 570 706 877 1019
EBITDA 173 290 332
Net Income 119 188 222 247
ROA 13.7 13.6 14.2
P/B Ratio 6.81 4.60 3.77
ROE 15.73 16.8 17.15
FCFF -22 96 200
FCFF Yield -0.39 1.67 3.47
Net Debt -69
BVPS 101.31 150 183

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 145.07 160.63 -9.69% 184.11 158.18 16.39% 185.65 140.07 32.54% 166.10 140.09 18.57%
Expenses 93.37 98.08 -4.80% 116.52 102.68 13.48% 119.70 98.59 21.41% 101.39 108.34 -6.41%
EBITDA 51.70 62.54 -17.33% 67.58 55.50 21.77% 65.95 41.49 58.95% 64.72 31.75 103.84%
EBIDTM 35.64% 38.94% 36.71% 35.09% 35.53% 29.62% 38.96% 22.66%
Other Income 2.67 2.22 20.27% 2.98 2.19 36.07% 2.10 3.06 -31.37% 2.52 2.47 2.02%
Interest 0.51 0.34 50.00% 0.42 0.60 -30.00% 0.51 0.49 4.08% 0.43 0.46 -6.52%
Depreciation 6.45 4.66 38.41% 6.08 3.91 55.50% 4.96 3.96 25.25% 4.74 3.98 19.10%
PBT 47.41 59.77 -20.68% 64.06 53.17 20.48% 62.58 40.10 56.06% 62.06 29.78 108.39%
Tax 12.62 15.13 -16.59% 13.68 16.24 -15.76% 15.80 10.31 53.25% 15.92 5.89 170.29%
PAT 34.79 44.64 -22.07% 50.38 36.93 36.42% 46.78 29.79 57.03% 46.15 23.88 93.26%
PATM 23.98% 27.79% 27.37% 23.35% 25.20% 21.27% 27.78% 17.05%
EPS 4.32 5.55 -22.16% 6.26 4.59 36.38% 5.81 3.70 57.03% 5.73 2.97 92.93%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 680.93 570.37 460.94 530.05 391.22 311.64 277.84 212.91 183.50 170.66 137.87 Net Sales Growth 13.68% 23.74% -13.04% 35.49% 25.54% 12.17% 30.50% 16.03% 7.52% 23.78% Cost Of Goods Sold 194.35 221.74 180.81 195.80 128.13 138.48 146.87 135.50 122.98 107.43 88.28 Gross Profit 486.58 348.63 280.13 334.24 263.09 173.16 130.96 77.41 60.52 63.22 49.59 GP Margin 71.46% 61.12% 60.77% 63.06% 67.25% 55.56% 47.14% 36.36% 32.98% 37.04% 35.97% Total Expenditure 430.98 394.68 332.50 316.06 218.07 213.26 213.41 190.96 166.38 151.00 120.71 Power & Fuel Cost - 21.37 20.95 14.07 9.24 8.97 8.06 7.03 6.93 6.64 5.25 % Of Sales - 3.75% 4.55% 2.65% 2.36% 2.88% 2.90% 3.30% 3.78% 3.89% 3.81% Employee Cost - 67.64 55.58 49.08 32.76 25.59 18.97 16.30 12.61 10.48 9.29 % Of Sales - 11.86% 12.06% 9.26% 8.37% 8.21% 6.83% 7.66% 6.87% 6.14% 6.74% Manufacturing Exp. - 34.03 28.71 20.01 14.05 15.29 18.59 14.36 9.35 5.82 3.91 % Of Sales - 5.97% 6.23% 3.78% 3.59% 4.91% 6.69% 6.74% 5.10% 3.41% 2.84% General & Admin Exp. - 21.66 16.73 11.05 8.76 9.08 6.92 8.02 8.17 10.14 4.47 % Of Sales - 3.80% 3.63% 2.08% 2.24% 2.91% 2.49% 3.77% 4.45% 5.94% 3.24% Selling & Distn. Exp. - 23.51 24.16 22.56 23.12 13.72 11.54 9.18 2.84 3.55 3.04 % Of Sales - 4.12% 5.24% 4.26% 5.91% 4.40% 4.15% 4.31% 1.55% 2.08% 2.20% Miscellaneous Exp. - 4.73 5.56 3.49 2.02 2.12 2.45 0.57 3.50 6.93 3.04 % Of Sales - 0.83% 1.21% 0.66% 0.52% 0.68% 0.88% 0.27% 1.91% 4.06% 4.69% EBITDA 249.95 175.69 128.44 213.99 173.15 98.38 64.43 21.95 17.12 19.66 17.16 EBITDA Margin 36.71% 30.80% 27.86% 40.37% 44.26% 31.57% 23.19% 10.31% 9.33% 11.52% 12.45% Other Income 10.27 10.96 9.94 7.58 5.00 11.07 8.33 8.59 7.45 2.39 2.41 Interest 1.87 5.15 3.08 4.20 4.08 6.85 10.22 10.75 11.76 10.04 6.92 Depreciation 22.23 15.81 11.81 10.12 6.76 6.38 5.43 5.33 4.75 3.95 2.49 PBT 236.11 165.69 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 10.16 Tax 58.02 46.58 33.63 55.44 43.72 22.82 17.68 5.74 2.40 2.37 1.95 Tax Rate 24.57% 28.11% 27.23% 26.75% 26.13% 23.71% 30.96% 39.70% 29.78% 29.40% 19.19% PAT 178.10 119.11 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 8.21 PAT before Minority Interest 178.10 119.11 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 8.21 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.16% 20.88% 19.49% 28.64% 31.59% 23.55% 14.19% 4.10% 3.08% 3.33% 5.95% PAT Growth 31.69% 32.55% -40.81% 22.83% 68.38% 86.20% 351.55% 54.24% -0.53% -30.69% EPS 22.12 14.80 11.16 18.86 15.35 9.12 4.90 1.08 0.70 0.71 1.02

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 815.37 699.46 615.69 268.58 149.19 93.79 54.66 45.89 41.72 37.38 Share Capital 16.10 16.10 16.10 14.64 14.64 14.64 14.64 14.64 14.64 4.88 Total Reserves 799.27 683.36 599.59 253.95 134.56 79.15 40.02 31.25 26.04 32.51 Non-Current Liabilities 28.98 25.04 19.38 30.86 31.85 24.36 44.86 51.30 39.21 23.35 Secured Loans 0.00 0.00 0.00 0.00 2.39 8.14 35.33 43.78 30.57 16.94 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.62 3.84 2.73 Long Term Provisions 0.80 5.88 2.93 1.30 1.03 0.69 0.58 0.00 0.00 0.00 Current Liabilities 79.57 95.78 99.70 146.02 155.39 134.91 145.88 144.15 150.26 114.88 Trade Payables 59.57 64.23 48.97 51.02 49.39 44.13 41.75 40.69 49.79 29.85 Other Current Liabilities 19.64 9.50 22.61 11.48 25.67 8.24 14.82 5.94 4.21 3.99 Short Term Borrowings 0.00 16.63 21.30 67.41 76.68 77.21 85.74 94.67 94.69 79.08 Short Term Provisions 0.37 5.42 6.82 16.11 3.64 5.33 3.56 2.84 1.57 1.96 Total Liabilities 923.92 820.28 734.77 445.46 336.43 253.06 245.40 241.34 231.19 175.61 Net Block 310.13 261.54 189.77 100.04 97.99 84.68 91.01 88.78 75.45 61.17 Gross Block 370.91 306.49 222.92 123.06 114.08 94.56 95.58 97.53 89.25 71.01 Accumulated Depreciation 60.77 44.95 33.14 23.03 16.08 9.88 4.57 8.75 13.80 9.84 Non Current Assets 523.43 355.39 237.22 180.00 138.44 120.39 125.82 126.31 102.29 72.55 Capital Work in Progress 148.82 67.63 43.41 78.79 40.21 35.35 34.38 35.58 25.18 10.96 Non Current Investment 63.80 25.30 0.05 0.05 0.05 0.05 0.12 0.10 0.10 0.10 Long Term Loans & Adv. 0.68 0.93 3.98 1.13 0.18 0.30 0.32 1.84 1.55 0.33 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 400.48 464.89 497.54 265.46 197.99 132.66 119.57 115.04 128.91 103.06 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 85.25 115.77 92.31 72.48 49.46 30.73 31.70 38.22 53.04 39.09 Sundry Debtors 111.68 84.66 115.18 73.50 52.49 59.95 53.40 49.61 42.34 35.36 Cash & Bank 74.96 157.58 227.91 89.28 1.54 1.73 2.73 5.58 7.09 5.06 Other Current Assets 128.59 17.25 13.28 4.01 94.51 40.25 31.74 21.63 26.44 23.55 Short Term Loans & Adv. 112.17 89.62 48.86 26.19 93.40 39.93 31.11 20.34 25.80 22.54 Net Current Assets 320.91 369.11 397.84 119.44 42.60 -2.25 -26.30 -29.11 -21.35 -11.82 Total Assets 923.91 820.28 734.76 445.46 336.43 253.05 245.39 241.35 231.20 175.61

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 113.31 63.61 48.80 75.89 116.06 48.88 27.75 27.30 13.50 -6.25 PBT 165.69 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 10.16 Adjustment 2.40 4.61 6.87 5.39 10.24 12.67 15.78 16.47 13.30 8.84 Changes in Working Capital -17.14 -33.81 -104.35 -66.82 36.60 -6.80 0.80 2.87 -6.74 -24.61 Cash after chg. in Working capital 150.95 94.29 109.76 105.88 143.07 62.98 31.04 27.40 14.62 -5.61 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -37.65 -30.68 -60.96 -29.99 -27.00 -14.09 -3.29 -0.10 -0.46 -0.24 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.66 -0.40 Cash From Investing Activity -173.57 -123.65 -59.82 -46.80 -24.52 4.83 -4.71 -26.61 -32.83 -23.22 Net Fixed Assets -145.61 -107.79 -64.48 -47.56 -24.38 0.05 3.15 -18.68 -32.46 -23.95 Net Investments -38.50 -25.25 0.00 0.00 0.00 0.07 -0.02 0.00 0.00 -0.01 Others 10.54 9.39 4.66 0.76 -0.14 4.71 -7.84 -7.93 -0.37 0.74 Cash from Financing Activity -22.36 -10.28 149.65 -14.52 -29.23 -49.92 -20.01 -2.21 21.36 30.22 Net Cash Inflow / Outflow -82.63 -70.32 138.63 14.57 62.31 3.79 3.03 -1.51 2.03 0.75 Opening Cash & Equivalents 157.58 227.91 89.28 74.70 12.40 8.61 5.58 7.09 5.06 4.31 Closing Cash & Equivalent 74.96 157.58 227.91 89.28 74.70 12.40 8.61 5.58 7.09 5.06

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 101.31 86.91 76.50 36.70 101.93 64.08 37.34 27.56 23.82 64.19 ROA 13.66% 11.56% 25.73% 31.61% 24.90% 15.82% 4.65% 2.40% 2.80% 5.37% ROE 15.73% 13.66% 34.34% 59.17% 60.42% 53.11% 22.16% 15.05% 17.20% 29.61% ROCE 22.31% 18.71% 43.34% 60.12% 49.67% 36.52% 18.63% 11.48% 12.27% 15.83% Fixed Asset Turnover 1.91 1.95 3.40 3.63 3.45 3.38 3.23 2.09 2.32 2.43 Receivable days 55.39 70.62 58.51 53.35 57.07 64.39 61.89 86.01 76.12 76.86 Inventory Days 56.71 73.53 51.10 51.64 40.70 35.46 47.13 85.36 90.25 84.22 Payable days 101.89 114.26 93.20 143.03 123.24 74.29 68.83 106.73 95.88 95.94 Cash Conversion Cycle 10.20 29.89 16.41 -38.04 -25.47 25.56 40.19 64.64 70.49 65.15 Total Debt/Equity 0.00 0.02 0.03 0.26 0.55 0.96 2.39 3.47 3.70 3.15 Interest Cover 33.18 41.04 50.37 42.01 15.05 6.59 2.34 1.69 1.80 2.47

Top Investors:

cohesion mk best ideas sub-trust

aditya birla sun life insurance company limited

hornbill orchid india fund

Annual Reports:

News Update:

Supriya Lifescience - Quarterly Results
13th Aug 2025, 18:00 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback